Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 5, 2013, Pages 401-407

  Bonilla, Ingrid M ^a,b   Sridhar, Arun ^c   Nishijima, Yoshinori ^a   Györke, Sandor ^b,d   Cardounel, Arturo J ^b,d   Carnes, Cynthia A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINSIDOMINE; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE; THAPSIGARGIN; URIC ACID;

ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; EXPERIMENTAL DOG; FEMALE; HEART ATRIUM; HEART ATRIUM APPENDAGE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART VENTRICLE; MALE; MEMBRANE STEADY POTENTIAL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; REPOLARIZATION;

ACTION POTENTIALS; ANIMALS; ATRIAL FUNCTION; DOGS; ENZYME INHIBITORS; FEMALE; MALE; MOLSIDOMINE; MYOCYTES, CARDIAC; NITRIC OXIDE DONORS; THAPSIGARGIN; VENTRICULAR FUNCTION;

EID: 84877629832     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31828748ca     Document Type: Article

References (54)

1. Sugamura K, Keaney JF Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 2011;51:978-992.
2. Han W, Fu S, Wei N, et al. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation. Int J Cardiol. 2008;130:165-173.
3. Sun Y. Oxidative stress and cardiac repair/remodeling following infarction. Am J Med Sci. 2007;334:197-205.
4. Kameda K, Matsunaga T, Abe N, et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. Eur Heart J. 2003; 24:2180-2185.
5. Wattanapitayakul SK, Bauer JA. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol Ther. 2001;89:187-206.
6. Reiter CD, Teng RJ, Beckman JS. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem. 2000; 275:32460-32466.
7. Nuriel T, Hansler A, Gross SS. Protein nitrotryptophan: formation, significance and identification. J Proteomics. 2011;74:2300-2312.
8. Souza JM, Peluffo G, Radi R. Protein tyrosine nitration - functional alteration or just a biomarker? Free Radic Biol Med. 2008;45:357-366.
9. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
10. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104: 174-180.
11. Lokuta AJ, Maertz NA, Meethal SV, et al. Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation. 2005;111:988-995.
12. Chesnais JM, Fischmeister R, Mery PF. Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart. J Physiol. 1999;518(pt 2):449-461.
13. Kohr MJ, Davis JP, Ziolo MT. Peroxynitrite increases protein phosphatase activity and promotes the interaction of phospholamban with protein phosphatase 2a in the myocardium. Nitric Oxide. 2009;20:217-221.
14. Bonilla IM, Sridhar A, Gyorke S, et al. Nitric oxide synthases and atrial fibrillation. Front Physiol. 2012;3:105.
15. Workman AJ, Pau D, Redpath CJ, et al. Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm. 2009;6:445-451.
16. Van Wagoner DR, Pond AL, Lamorgese M, et al. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 1999;85:428-436.
17. Nishijima Y, Sridhar A, Viatchenko-Karpinski S, et al. Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathy. Life Sci. 2007;81:1152-1159.
18. Sridhar A, Nishijima Y, Terentyev D, et al. Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res. 2009;84:227-236.
19. Kubalova Z, Terentyev D, Viatchenko-Karpinski S, et al. Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci U S A. 2005;102:14104-14109.
20. Nishijima Y, Sridhar A, Bonilla I, et al. Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res. 2011;91:71-79.
21. Kohr MJ, Wang H, Wheeler DG, et al. Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes. Cardiovasc Res. 2008;77:353-361.
22. Chen W, Druhan LJ, Chen CA, et al. Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: transition from reversible to irreversible enzyme inhibition. Biochemistry. 2010;49:3129-3137.
23. Sridhar A, da Cunha DN, Lacombe VA, et al. The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization. Br J Pharmacol. 2007;152:870-879.
24. Van Wagoner DR, Pond AL, McCarthy PM, et al. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res. 1997;80:772-781.
25. Kooy NW, Lewis SJ, Royall JA, et al. Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med. 1997;25:812-819.
26. Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids. 2003;25:295-311.
27. Jones LH. Chemistry and biology of biomolecule nitration. Chem Biol. 2012;19:1086-1092.
28. Franz MR, Karasik PL, Li C, et al. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol. 1997;30:1785-1792.
29. Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
30. Kaab S, Barth AS, Margerie D, et al. Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. J Mol Med (Berl). 2004; 82:308-316.
31. Hanna N, Cardin S, Leung TK, et al. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res. 2004;63:236-244.
32. Cardin S, Pelletier P, Libby E, et al. Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure. J Mol Cell Cardiol. 2008;45:821-831.
33. Beuckelmann DJ, Nabauer M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:379-385.
34. Sridhar A, Nishijima Y, Terentyev D, et al. Repolarization abnormalities and after depolarizations in a canine model of sudden cardiac death. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1463-R1472.
35. Snook JH, Li J, Helmke BP, et al. Peroxynitrite inhibits myofibrillar protein function in an in vitro assay of motility. Free Radic Biol Med. 2008;44:14-23.
36. Frank KF, Bolck B, Erdmann E, et al. Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res. 2003;57: 20-27.
37. Terentyev D, Gyorke I, Belevych AE, et al. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circ Res. 2008;103:1466-1472.
38. Belevych AE, Terentyev D, Viatchenko-Karpinski S, et al. Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death. Cardiovasc Res. 2009;84: 387-395.
39. Wagner S, Rokita AG, Anderson ME, et al. Redox regulation of sodium and calcium handling. Antioxid Redox Signal. October 3, 2012 [Epub ahead of print].
40. Erickson JR, Joiner ML, Guan X, et al. A dynamic pathway for calciumindependent activation of CaMKII by methionine oxidation. Cell. 2008; 133:462-474.
41. Babu GJ, Bhupathy P, Carnes CA, et al. Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. J Mol Cell Cardiol. 2007;43:215-222.
42. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18:655-673.
43. Fernandez-Velasco M, Ruiz-Hurtado G, Hurtado O, et al. TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am J Physiol Heart Circ Physiol. 2007;293:H238-H245.
44. Priebe L, Beuckelmann DJ. Simulation study of cellular electric properties in heart failure. Circ Res. 1998;82:1206-1223.
45. Winslow RL, Rice J, Jafri S, et al. Mechanisms of altered excitation- contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ Res. 1999;84:571-586.
46. Sun X, Wang HS. Role of the transient outward current (Ito) in shaping canine ventricular action potential - a dynamic clamp study. J Physiol. 2005;564(pt 2):411-419.
47. Fulop L, Banyasz T, Magyar J, et al. Reopening of L-type calcium channels in human ventricular myocytes during applied epicardial action potentials. Acta Physiol Scand. 2004;180:39-47.
48. Banyasz T, Fulop L, Magyar J, et al. Endocardial versus epicardial differences in L-type calcium current in canine ventricular myocytes studied by action potential voltage clamp. Cardiovasc Res. 2003;58:66-75.
49. Sah R, Ramirez RJ, Oudit GY, et al. Regulation of cardiac excitation- contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)). J Physiol. 2003;546(pt 1):5-18.
50. Rabkin SW, Klassen SS. Nitric oxide differentially regulates the gene expression of caspase genes but not some autophagic genes. Nitric Oxide. 2007;16:339-347.
51. Tao L, Gao E, Hu A, et al. Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br J Pharmacol. 2006;149:311-318.
52. Suzuki K, Kostin S, Person V, et al. Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol. 2001;33:983-994.
53. Guo D, Lian J, Liu T, et al. Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents. Heart Rhythm. 2011;8:762-769.
54. Varkevisser R, Wijers SC, van der Heyden MA, et al. Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo. Heart Rhythm. 2012;9:1718-1726.